ID   Mel JuSo ABCB5 KO clone HO4
AC   CVCL_B7EI
DR   cancercelllines; CVCL_B7EI
DR   Wikidata; Q112930111
RX   CelloPub=CLPUB00695;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 46; ABCB5.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1403 ! Mel JuSo
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 30-01-24; Version: 6
//
RX   CelloPub=CLPUB00695;
RA   Guerit E.;
RT   "Generation of an ABCB5-knockout human melanoma cell line using the
RT   CRISPR/Cas9 genome editing-tool: study of ABCB5 subcellular
RT   localization by cell fractionation.";
RL   Thesis MSc (2019), University of Namur, Belgium.
//